Healthy Expectancy Through Routine Antenatal STI Screening

Recruiting N/A Interventional Study
Antenatal Health Antenatal Care STI Chlamydia Trachomatis Infection in Pregnancy Chlamydia Chlamydia Trachomatis Chlamydia Trachomatis Infection Preterm Birth
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
15 and older
Sex
Female
Study type
Interventional
Purpose
Health Services Research
Participants needed
2,000 (estimated)
Sponsor
Adriane Wynn · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study will evaluate whether routine screening and treatment for two common sexually transmitted infections, chlamydia and gonorrhoea, during pregnancy can reduce preterm birth and other poor birth outcomes in Botswana, and whether this approach is affordable and cost-effective for the health system. About 2,000 pregnant women attending their first antenatal care visit at up to 10 government …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Asymptomatic for cervicovaginitis at first ANC (i.e., not syndromically treated for an STI by clinic midwives at first ANC) 2. Age ≥ 15 years 3. Currently pregnant 4. ≤20 weeks gestation (based on gestational age in obstetric record or last menstrual period if gestational age…
Contacts

Adriane Wynn, PhD MPP

+1 (916) 662-1497

awynn@health.ucsd.edu

CONTACT

Chelsea Morroni, MBChB, DFSRH, MPH, PhD

cmorroni@ed.ac.uk

CONTACT